other

Updated:

Anika Therapeutics

Anika redefines orthopedic care with clinically proven hyaluronic acid based solutions for regenerative medicine and osteoarthritis pain management worldwide.

Anika Therapeutics

Anika redefines orthopedic care with clinically proven hyaluronic acid based solutions for regenerative medicine and osteoarthritis pain management worldwide.

General information

Firm type

other

Location

Region

North America

Country

United States

City

Bedford

Corporate office

32 Wiggins Avenue, Bedford, MA 01730, USA

Additional offices

Warsaw, IN, USA · Padova, Italy

Sector focus

Medical DeviceOrthopedicsSports MedicineRegenerative Medicine

Frequently asked questions

What is Anika Therapeutics' core technology platform?

Anika's entire product portfolio is built around hyaluronic acid (HA), the naturally occurring molecule that lubricates joints. The company has refined proprietary HA formulations over three decades into three distinct application categories: viscosupplementation injections for osteoarthritis pain (Monovisc, Orthovisc, Cingal), regenerative scaffolds for soft-tissue and cartilage repair (Integrity, Hyalofast), and an injectable bone substitute (Tactoset). Cingal combines HA with a fast-acting corticosteroid for dual-action pain relief — a formulation available in over 45 countries outside the U.S.

How does Anika's U.S. commercial model split between distribution partners and a direct salesforce?

Anika relies on J&J MedTech as the exclusive U.S. distributor for its viscosupplementation injections Orthovisc and Monovisc. For the regenerative portfolio — led by the Integrity rotator-cuff scaffold — the company has built a direct sales team. Outside the U.S., Anika distributes most products through a network of global commercial partners, with Cingal as the flagship international offering.

Which clinical indications does Anika currently address with its regenerative products?

The Integrity implant targets rotator-cuff and other tendon repair procedures, functioning as a porous HA-based scaffold that supports tissue regeneration. Hyalofast is an off-the-shelf, single-stage scaffold for cartilage repair designed to promote hyaline-like cartilage regeneration. Tactoset addresses insufficiency fractures and augments hardware such as suture anchors by providing an HA-enhanced injectable bone substitute that sets in situ.

Where are Anika's manufacturing and R&D operations located?

Anika's headquarters and primary operations are in Bedford, Massachusetts. The firm maintains an additional U.S. office in Warsaw, Indiana, focused on customer service. Its European base is in Padova, Italy, managed through Anika Therapeutics S.r.l., which handles international sales support for products including Hyalofast and Cingal. This dual-continent setup supports both U.S. manufacturing and European distribution.

In which countries is Cingal currently available?

Cingal is not sold in the United States. It is available in over 45 countries outside the U.S. through Anika's international distributor network, with the Padova, Italy office serving as the commercial-support hub for global partners. The specific country list is not published on Anika's website; contact information for international distribution partners is handled through the company's Bedford and Padova offices.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Bedford other profiles